Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse
Authors
Keywords
-
Journal
IMMUNOLOGIC RESEARCH
Volume 52, Issue 3, Pages 240-249
Publisher
Springer Nature
Online
2012-04-05
DOI
10.1007/s12026-012-8332-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma
- (2011) A Tanaka et al. GENE THERAPY
- Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma
- (2011) D. Atanackovic et al. HAEMATOLOGICA
- Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection
- (2011) K. A. Millington et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Augmenting Therapy of Ovarian Cancer Efficacy by Secreting IL-21 Human Umbilical Cord Blood Stem Cells in Nude Mice
- (2010) Weihua Hu et al. CELL TRANSPLANTATION
- Evaluation of molecular markers of mesenchymal phenotype in melanoma
- (2010) Leann M. Mikesh et al. MELANOMA RESEARCH
- mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
- (2010) Robert Schickel et al. MOLECULAR CELL
- Emerging strategies for the identification and targeting of cancer stem cells
- (2010) Jun Dou et al. TUMOR BIOLOGY
- Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model
- (2010) Fengshu Zhao et al. VACCINE
- Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model
- (2010) Hye-Sung Kim et al. VACCINE
- Vaccination strategies in patients with renal cell carcinoma
- (2009) Anne Marie Asemissen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Investigation on the anti-tumor efficacy by expression of GPI-anchored mIL-21 on the surface of B16F10 cells in C57BL/6 mice
- (2009) Fengshu Zhao et al. IMMUNOBIOLOGY
- Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
- (2009) Her-Young Su et al. INTERNATIONAL JOURNAL OF CANCER
- IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma
- (2008) Klaus Stensgaard Frederiksen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin 21 Enhances Antibody-Mediated Tumor Rejection
- (2008) M. J. Smyth et al. CANCER RESEARCH
- A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition
- (2008) C. P. Bracken et al. CANCER RESEARCH
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma
- (2008) John A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started